Comparative study of technetium-99m-sestamibi and thallium-201 SPECT in predicting chemotherapeutic response in small cell lung cancer

Journal of Nuclear Medicine

Volumn 39, Issue 9, 1998, Pages 1626-1629

  Yamamoto, Yuka ^a   Nishiyama, Yoshihiro ^b   Satoh, Katashi ^b   Takashima, Hitoshi ^b   Ohkawa, Motoomi ^b   Fujita, Jiro ^b   Kishi, Toshiyuki ^b   Matsuno, Shinsuke ^b   Tanabe, Masatada ^b  

^a KAGAWA UNIVERSITY   (Japan)

^b NONE

Author keywords

Chemotherapy; Dual isotope imaging; Small cell lung cancer; Technetium 99m sestamibi; Thallium 201 chloride

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; ETOPOSIDE; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; MITOMYCIN C; THALLIUM 201; VINCRISTINE; VINDESINE;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER REGRESSION; CLINICAL ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG RESPONSE; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LUNG SMALL CELL CANCER; MALE; PREDICTION; PRIORITY JOURNAL; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, SMALL CELL; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; RADIOPHARMACEUTICALS; TECHNETIUM TC 99M SESTAMIBI; THALLIUM; THALLIUM RADIOISOTOPES; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 0031702671     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Matsuno S, Tanabe M, Kawasaki Y, et al. Effectiveness of planar image and single-photon emission computed tomography of thallium-201 compared with gallium-67 in patients with primary lung cancer. Eur J Nucl Med 1992;19:86-95.
2. Tonami N, Shuke N, Yokoyama K, et al. Thallium-201 single photon emission computed tomography in the evaluation of suspected lung cancer. J Nucl Med 1989;30:997-1004.
3. 201Tl-a fundamental study through phantom experiments. Radioisotopes 1996;45:369-374.
4. Kishida T. Mechanism of thallium-201 accumulation to thyroid gland: clinical usefulness of dynamic study in thallium-201 chloride scintigraphy for differential diagnosis of thyroid nodules. Kagu Igaku 1987;24:991-1004.
5. 201Tl-chloride. Eur J Nucl Med 1978;3:81-86.
6. 201Tl uptake in tumours. Eur J Nucl Med 1989;15:376-379.
7. Hassan IM, Sahweil A, Constantinides C, et al. Uptake and kinetics of Tc-99m hexakis 2-methoxy isobutyl isonitrile in benign and malignant lesions in the lungs. Clin Nucl Med 1989;14:333-340.
8. 201Tl. Clin Nucl Med 1992;17:171-176.
9. Kao CH, Wang SJ, Lin WY, Hsu CY, Liao SQ, Yeh SH. Differentiation of single solid lesions in the lungs by means of single-photon emission tomography with technetium-99m methoxyisobutylisonitrile. Eur J Nucl Med 1993;20:249-254.
10. Desai SP, Yuille DL. Visualization of a recurrent carcinoid tumor and an occult distant metastasis by technetium-99m-sestamibi. J Nucl Med 1993;34:1748-1751.
11. 99mTc sestamibi cardiac imaging. Clin Nucl Med 1993;18:448-449.
12. 99mTC MIBI in undifferentiated mesenchymal tumor and its metastatic lung lesions. Clin Nucl Med 1992;17:144-145.
13. Nishiyama Y, Kawasaki Y, Yamamoto Y, et al. Technetium-99m-MIBI thallium-201 scintigraphy of primary lung cancer. J Nucl Med 1997;38:1358-1361.
14. Chiu ML, Kronauge JF, Piwnica-Worms D. Effect of mitochondrial and plasma membrane potentials on accumulation of hexakis (2-methoxyisobutylisonitrile) technetium (I) in cultured mouse fibroblasts. J Nucl Med 1990;31:1646-1653.
15. Ballinger JR, Hua HA, Berry BW, Firby P, Boxen I. Technetium-99m-sestamibi as an agent for imaging P-glycoprotein-mediated multi-drug resistance: in vitro and in vivo studies in a rat breast tumour cell line and its doxorubicin-resistant variant. Nucl Med Commun 1995;16:253-257.
16. Dimitrakopoulou-Strauss A, Strauss LG, Goldschmidt H, Lorenz WJ, Maier-Borst W, Van Kaick G. Evaluation of tumour metabolism and multidrug resistance in patients with treated malignant lymphomas. Eur J Nucl Med 1995;22:434-442.
17. Rao VV, Chiu ML, Kronauge JF, Piwnica-Worms D. Expression of recombinant human multidrug resistance P-glycoprotein in insect cells confers decreased accumulation of technetium-99m-sestamibi. J Nucl Med 1994;35:510-515.
18. 99mTc-MIBI in HeLa cell. Kaku Igaku 1995;32:651-658.
19. Ford JM, Hait MN. Pharmacology of drugs that alter multidrug resistance in cancer. Pharmacol Rev 1990;42:155-199.
20. Piwnica-Worms D, Chiu ML, Budding J, et al. Functional imaging of multidrug-resistant P-glycoptotein with an organotechnetium complex. Cancer Res 1993;53:977-984.
21. Chan HLS, Haddad G, Thorner PS, et al. P-Glycoprotein expression as a predictor of the outcome of therapy for neuroblastoma. N Engl J Med 1991;325:1608-1614.
22. Moretti JL, Caglar M, Boaziz C, Caillat-Vigneron N, Morere JF. Sequential functional imaging with lechnetium-99m hexakis-2-methoxyisobutylisonitrile and indium-111 octreotide: can we predict the response to chemotherapy in small cell lung cancer? Eur J Nucl Med 1995;22:177-180.
23. Morrow CS, Cowan KH. Mechanisms of antineoplastic drug resistance. In: De Vita V, Hellman S, Rosenberg SA, eds. Cancer: principles and practice of oncology. Philadelphia: Lippincott: 1993:340-348.
24. Deeley RG, Grant CE, Almquist KC, et al. Multidrug resistance mediated by the 190 kDa MRP: a novel member of the ATP-binding cassette transporter superfamily. Proc Am Assoc Cancer Res 1994;35:698-699.
25. 99mTc-sestamibi accumulation in Pgp-positive and MRP-positive cell lines [Abstract]. Proc Am Assoc Cancer Res 1995;36:358.
26. Cole SPC, Bhardwaj G, Gerlach JH, et al. Overexpression of a transporter gene in a multidrug-resistant human cancer cell line. Science 1992;258:1650-1654.
27. Lai SL, Goldstein LJ, Gottesman MM, et al. MDR1 gene expression in lung cancer. J Natl Cancer Inst 1989;81:1144-1150.